No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleonly females |
313377 |
2. Check conditionsNone |
313377 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
114 |
4. Check minimum number of eventsNone |
114 |
5. Include endpointsNone |
114 |
6. Filter based on genotype QC (FinnGen only) |
105 |
Control definitions (FinnGen only)
- Control exclude
- N14_FEMALEGENNONINF
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- N83
- Name in latin
- Atrophia acquisita ovarii et tubae uterinae
Similar endpoints
↥List of similar endpoints to
Acquired atrophy of ovary and fallopian tube
based on the number of shared cases.
Similar with more cases:
- Noninflammatory disorders of female genital tract
- Genitourinary diseases
- Any operation in hilmo
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 567 | 567 | - |
| Only index persons | 554 | 554 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | - |
| Only index persons | 0.02 | 0.02 | - |
| Median age at first event (years) | |||
| Whole population | - | 41.06 | - |
| Only index persons | - | 40.51 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 105 | 105 | - |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | - |
| Median age at first event (years) | 41.21 | 41.21 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 107
- Matched controls
- 1070
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N83.3
ICD-10 Finland
Acquired atrophy of ovary and fallopian tube
+∞
154.3
107
*
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
141.7
51.8
52
7
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
10.5
34.0
70
163
N80.3
ICD-10 Finland
Endometriosis of pelvic peritoneum
+∞
25.0
23
*
N95.1
ICD-10 Finland
Menopausal and female climacteric states
+∞
25.0
23
*
N80.1
ICD-10 Finland
Endometriosis of ovary
107.1
17.1
18
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
5.3
16.3
52
163
JAL21
NOMESCO Finland
Laparoscopic excision or destruction of lesion of peritoneum
+∞
13.8
13
*
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
12.2
13.7
25
26
LCA06
NOMESCO Finland
Biopsy of endometrium
12.4
12.8
23
23
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
6.7
12.7
23
42
N80.9
ICD-10 Finland
Endometriosis, unspecified
146.5
12.7
13
*
N84.0
ICD-10 Finland
Polyp of corpus uteri
+∞
11.7
11
*
N80.0
ICD-10 Finland
Endometriosis of uterus
+∞
11.7
11
*
UJF32
NOMESCO Finland
Coloscopy
4.4
11.7
40
128
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.7
10.2
61
282
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
22.7
10.1
14
7
N97.9
ICD-10 Finland
Female infertility, unspecified
29.2
10.1
13
5
LAC01
NOMESCO Finland
Laparoscopic excision of ovarian cyst
60.6
9.8
11
*
SPAT1254
SPAT
Administration of medicine
5.0
9.0
22
53
N83.1
ICD-10 Finland
Corpus luteum cyst
97.4
8.5
9
*
LBF01
NOMESCO Finland
Laparoscopic perfusion of Fallopian tube
+∞
8.4
8
*
N83.8
ICD-10 Finland
Other noninflammatory disorders of ovary, fallopian tube and broad ligament
+∞
8.4
8
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
5.0
8.4
20
47
J02AC01
ATC
fluconazole; systemic
3.3
8.2
69
378
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
3.4
8.1
73
416
N95.0
ICD-10 Finland
Postmenopausal bleeding
20.2
7.8
11
6
N81.6
ICD-10 Finland
Rectocele
85.8
7.5
8
*
ULC02
NOMESCO Finland
Hysteroscopy
17.3
7.4
11
7
N95.2
ICD-10 Finland
Postmenopausal atrophic vaginitis
+∞
7.4
7
*
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
9.9
7.3
14
16
JAH01
NOMESCO Finland
Laparoscopy
9.9
7.3
14
16
N83.0
ICD-10 Finland
Follicular cyst of ovary
32.4
7.3
9
*
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
9.3
7.1
14
17
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.1
6.9
39
167
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
42.9
6.9
8
*
N81.2
ICD-10 Finland
Incomplete uterovaginal prolapse
42.9
6.9
8
*
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
8.3
6.7
14
19
N73.6
ICD-10 Finland
Female pelvic peritoneal adhesions
74.1
6.5
7
*
L02AE02
ATC
leuprorelin; implant, parenteral
19.4
6.4
9
5
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
4.0
6.4
20
58
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
8.5
6.3
13
17
N97.8
ICD-10 Finland
Female infertility of other origin
+∞
6.3
6
*
N80.5
ICD-10 Finland
Endometriosis of intestine
+∞
6.3
6
*
TLW12
NOMESCO Finland
Insertion of frozen embryo
+∞
6.3
6
*
N81.1
ICD-10 Finland
Cystocele
+∞
6.3
6
*
LC2HE
NOMESCO Finland
Hystero-salpingography with ultrasound
16.2
6.0
9
6
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
20
57
4.09
6.53
1.5
1.4
—
—
—
0
0
11
16
7.52
5.10
1.7
1.3
53.09
87.94
pmol/l
0.43
11
16
88
666
2.81
4.21
4.8
4.4
9.05
10.77
mm/h
0.91
83
629
24
117
2.36
3.07
2.0
2.0
—
—
—
0
0
52
344
2.00
3.06
5.4
3.0
0.27
0.03
estimate
0.40
11
69
45
283
2.02
3.05
3.5
3.2
60.39
21.88
ng/l
0.35
22
176
66
476
2.01
3.02
5.5
3.2
0.00
0.00
estimate
-0.00
14
88
66
477
2.00
2.99
5.5
3.2
0.00
16.92
estimate
0.50
13
96
65
468
1.99
2.97
5.6
3.2
0.00
0.00
estimate
-0.00
12
89
7
13
5.68
2.92
1.0
1.4
—
—
—
0
0
35
206
2.04
2.81
6.1
2.8
1.02
1.02
kg/l
0.45
29
131
7
14
5.27
2.77
1.0
1.4
—
—
—
0
0
7
16
4.60
2.52
1.0
1.6
—
—
—
0
0
63
466
1.86
2.48
6.2
6.5
9.16
9.41
umol/l
0.12
63
447
32
191
1.96
2.43
1.4
1.3
3.65
12.42
u/ml
1.11
13
77
6
12
5.22
2.43
1.0
1.3
—
—
—
0
0
69
529
1.86
2.38
6.5
10.4
4.31
4.14
e9/l
0.29
64
467
58
422
1.82
2.37
6.4
6.8
1.21
1.22
mmol/l
0.09
51
371
33
202
1.92
2.32
1.5
1.3
—
—
—
0
0
38
244
1.86
2.32
3.9
2.9
0.00
0.01
estimate
—
10
75
14
61
2.49
2.26
1.3
2.1
—
—
—
0
0
34
216
1.84
2.12
1.4
1.3
7.82
29.74
iu/ml
2.03
14
59
18
91
2.18
2.10
1.9
1.9
—
—
—
0
0
99
892
2.47
1.93
6.7
5.5
1.63
1.88
mu/l
2.02
93
836
14
66
2.29
1.92
1.2
2.0
—
—
—
0
0
9
34
2.79
1.91
1.3
1.2
—
—
—
0
0
31
200
1.77
1.82
2.0
1.8
1.45
1.05
mg/l
0.52
22
152
8
30
2.80
1.76
2.9
2.1
27.63
24.61
mmol/l
—
8
30
5
13
3.98
1.73
1.8
1.2
—
—
—
0
0
5
13
3.98
1.73
1.8
1.2
—
—
—
0
0
56
430
1.63
1.70
3.1
2.4
—
—
estimate
—
0
0
10
41
2.58
1.69
1.6
1.6
—
—
—
0
0
16
86
2.01
1.61
2.3
1.9
—
—
—
0
0
8
33
2.54
1.57
3.6
2.9
60.95
41.10
%
—
8
33
7
27
2.70
1.54
1.4
1.7
—
—
—
0
0
7
29
2.51
1.42
2.6
1.9
—
—
—
0
0
18
106
1.84
1.40
1.6
2.1
—
—
—
0
0
96
869
2.02
1.39
5.0
4.4
5.86
5.85
mmol/l
0.02
89
813
11
54
2.16
1.38
1.2
2.0
—
—
—
0
0
5
17
3.03
1.37
1.4
1.5
—
—
—
0
0
0
39
0.00
1.37
0.0
1.5
—
1.22
—
0
27
0
39
0.00
1.37
0.0
1.5
—
1.29
—
0
27
0
39
0.00
1.37
0.0
1.5
—
1.02
—
0
27
0
40
0.00
1.36
0.0
1.6
—
66.18
—
0
32
100
927
2.20
1.33
5.0
4.5
4.91
4.94
mmol/l
0.11
94
872
36
263
1.56
1.28
6.3
3.2
0.00
0.00
estimate
-0.00
13
91
8
37
2.25
1.24
3.6
2.4
1.37
1.14
%
—
8
37
5
19
2.71
1.23
1.6
1.5
—
—
—
0
0
19
119
1.73
1.22
1.6
2.3
—
—
—
0
0
52
415
1.49
1.22
1.9
1.8
1.44
1.32
mmol/l
0.49
44
360
33
239
1.55
1.21
1.2
1.3
0.50
2.20
u/ml
—
8
66
93
844
1.78
1.18
5.7
5.4
37.71
38.68
mmol/mol
0.68
85
804
5
20
2.57
1.16
1.4
2.3
—
—
—
0
0
14
81
1.84
1.15
2.4
3.4
—
—
—
0
0
10
51
2.06
1.15
2.4
3.9
77.10
224.68
ng/l
—
10
46
8
40
2.08
1.15
1.4
2.0
—
—
—
0
0
75
650
1.51
1.13
4.3
3.0
33.29
37.14
u/l
0.48
75
625
13
74
1.86
1.12
3.0
3.3
6.02
5.94
kpa
0.10
13
74
5
22
2.33
1.04
1.6
2.0
—
—
—
0
0
16
100
1.71
1.04
8.4
7.9
103.88
104.46
mmol/l
0.16
16
100
99
926
1.92
1.02
4.9
4.4
1.60
1.59
mmol/l
0.06
91
869
7
35
2.07
1.02
14.0
9.4
26.29
24.77
mmol/l
—
7
35
6
27
2.29
0.95
1.5
1.7
—
—
—
0
0
9
52
1.80
0.95
1.4
1.5
—
—
—
0
0
74
654
1.43
0.90
3.6
3.3
—
—
—
0
0
88
804
1.53
0.89
19.3
16.9
13.49
13.52
%
0.08
88
792
8
47
1.76
0.83
14.0
10.7
0.69
0.57
%
—
8
47
13
82
1.67
0.82
1.8
4.7
247.46
242.65
u/l
0.07
13
77
99
937
1.76
0.80
5.7
5.1
2.85
2.91
mmol/l
0.31
91
881
5
23
2.23
0.77
1.6
1.5
—
—
—
0
0
5
23
2.23
0.77
1.2
1.1
—
—
—
0
0
5
24
2.13
0.75
1.2
1.1
557.40
501.42
mg/l
—
5
24
5
24
2.13
0.75
1.6
1.9
—
—
—
0
0
11
69
1.66
0.71
10.1
10.9
120.00
117.64
g/l
0.16
11
69
12
78
1.61
0.69
2.3
2.8
4.45
4.67
pmol/l
0.39
12
69
7
43
1.67
0.68
2.3
1.3
1.21
1.18
g/l
—
7
38
28
221
1.36
0.64
2.5
2.0
—
—
—
0
0
8
49
1.68
0.64
14.1
10.4
1.78
1.20
%
—
8
49
5
30
1.70
0.62
1.0
1.2
—
—
—
0
0
15
106
1.48
0.62
2.3
5.0
1.01
1.04
mmol/l
0.19
15
99
43
365
1.30
0.60
2.4
2.2
94.10
92.86
pmol/l
0.06
18
179
94
889
1.47
0.59
16.2
12.5
85.06
84.76
ml/min/173m2
0.06
86
810
92
868
1.43
0.57
4.1
3.8
1.25
1.22
mmol/l
0.20
84
811
7
46
1.56
0.49
2.6
4.0
25.36
25.45
mmol/l
—
7
46
27
223
1.28
0.46
1.5
1.6
—
—
—
0
0
8
55
1.49
0.44
4.5
7.3
25.39
25.22
mmol/l
—
8
55
5
31
1.64
0.43
1.0
1.5
—
—
—
0
0
5
31
1.64
0.43
1.2
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
12
89
1.39
0.40
1.2
2.2
326.00
346.24
nmol/l
0.15
12
83
5
35
1.45
0.40
1.8
1.7
—
—
—
0
0
11
81
1.40
0.38
12.0
6.0
—
—
—
0
0
6
41
1.49
0.37
15.7
11.3
16.93
15.27
%
—
6
41
16
135
1.22
0.23
3.6
2.7
0.21
1.09
e6/l
—
10
69
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.9
—
6.20
—
0
11
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
84
814
1.15
0.18
25.0
17.1
331.15
330.55
g/l
0.26
84
809
17
148
1.18
0.18
4.5
2.4
2.48
2.45
mmol/l
0.44
17
134
7
62
1.14
0.17
2.1
3.6
1.21
1.24
mmol/l
—
7
53
30
276
1.12
0.16
3.4
4.1
1.12
7.04
mg/mmol
1.53
21
163
11
94
1.19
0.13
1.9
1.6
1.44
1.34
%
0.23
11
75
14
124
1.15
0.12
3.6
2.8
3.25
3.27
e6/l
—
8
56
5
46
1.09
0.10
1.6
1.3
0.85
0.92
g/l
—
5
46
6
54
1.12
0.09
1.0
1.5
—
—
—
0
0
14
127
1.12
0.08
1.6
2.4
14.31
13.53
umol/l
0.12
14
120
13
118
1.12
0.07
1.7
2.4
2.59
2.38
g/l
0.60
13
112
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
87.00
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.2
—
1411.96
—
0
5
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
79.60
—
0
5
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
1.06
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
-0.00
0.0
1.0
—
122.00
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.60
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
27.33
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
1.59
—
0
7
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint N14_ATROPHOV and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have N14_ATROPHOV.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: N14_ATROPHOV – Acquired atrophy of ovary and fallopian tube
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data